The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Drug and Gene Delivery System Market Research Report 2024

Global Drug and Gene Delivery System Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1739741

No of Pages : 112

Ask Your Query

Synopsis
Global Drug and Gene Delivery System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Drug and Gene Delivery System market research.

Key companies engaged in the Drug and Gene Delivery System industry include Pfizer, Johnson & Johnson, Novartis, Roche, Merck & Co., Sanofi, GlaxoSmithKline, AbbVie and AstraZeneca, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Drug and Gene Delivery System were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Drug and Gene Delivery System market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Drug and Gene Delivery System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Pfizer
  • Johnson & Johnson
  • Novartis
  • Roche
  • Merck & Co.
  • Sanofi
  • GlaxoSmithKline
  • AbbVie
  • AstraZeneca
  • Bayer
  • Bristol-MyersSquibb
  • Celgene
  • Amgen
  • Biogen
  • Gilead Sciences
  • Illumina
  • Regeneron Pharmaceuticals
  • Vertex Pharmaceuticals
  • Moderna
  • CRISPR Therapeutics

Segment by Type

  • Drug Delivery System
  • Gene Delivery System

Segment by Application

  • Diabetes
  • Central Nervous System
  • Infectious Disease
  • Oncology
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Drug and Gene Delivery System report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug and Gene Delivery System Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Drug Delivery System
1.2.3 Gene Delivery System
1.3 Market by Application
1.3.1 Global Drug and Gene Delivery System Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diabetes
1.3.3 Central Nervous System
1.3.4 Infectious Disease
1.3.5 Oncology
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug and Gene Delivery System Market Perspective (2018-2029)
2.2 Drug and Gene Delivery System Growth Trends by Region
2.2.1 Global Drug and Gene Delivery System Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug and Gene Delivery System Historic Market Size by Region (2018-2023)
2.2.3 Drug and Gene Delivery System Forecasted Market Size by Region (2024-2029)
2.3 Drug and Gene Delivery System Market Dynamics
2.3.1 Drug and Gene Delivery System Industry Trends
2.3.2 Drug and Gene Delivery System Market Drivers
2.3.3 Drug and Gene Delivery System Market Challenges
2.3.4 Drug and Gene Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug and Gene Delivery System Players by Revenue
3.1.1 Global Top Drug and Gene Delivery System Players by Revenue (2018-2023)
3.1.2 Global Drug and Gene Delivery System Revenue Market Share by Players (2018-2023)
3.2 Global Drug and Gene Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug and Gene Delivery System Revenue
3.4 Global Drug and Gene Delivery System Market Concentration Ratio
3.4.1 Global Drug and Gene Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug and Gene Delivery System Revenue in 2022
3.5 Drug and Gene Delivery System Key Players Head office and Area Served
3.6 Key Players Drug and Gene Delivery System Product Solution and Service
3.7 Date of Enter into Drug and Gene Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug and Gene Delivery System Breakdown Data by Type
4.1 Global Drug and Gene Delivery System Historic Market Size by Type (2018-2023)
4.2 Global Drug and Gene Delivery System Forecasted Market Size by Type (2024-2029)
5 Drug and Gene Delivery System Breakdown Data by Application
5.1 Global Drug and Gene Delivery System Historic Market Size by Application (2018-2023)
5.2 Global Drug and Gene Delivery System Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drug and Gene Delivery System Market Size (2018-2029)
6.2 North America Drug and Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Drug and Gene Delivery System Market Size by Country (2018-2023)
6.4 North America Drug and Gene Delivery System Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug and Gene Delivery System Market Size (2018-2029)
7.2 Europe Drug and Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Drug and Gene Delivery System Market Size by Country (2018-2023)
7.4 Europe Drug and Gene Delivery System Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug and Gene Delivery System Market Size (2018-2029)
8.2 Asia-Pacific Drug and Gene Delivery System Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Drug and Gene Delivery System Market Size by Region (2018-2023)
8.4 Asia-Pacific Drug and Gene Delivery System Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug and Gene Delivery System Market Size (2018-2029)
9.2 Latin America Drug and Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Drug and Gene Delivery System Market Size by Country (2018-2023)
9.4 Latin America Drug and Gene Delivery System Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug and Gene Delivery System Market Size (2018-2029)
10.2 Middle East & Africa Drug and Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Drug and Gene Delivery System Market Size by Country (2018-2023)
10.4 Middle East & Africa Drug and Gene Delivery System Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Drug and Gene Delivery System Introduction
11.1.4 Pfizer Revenue in Drug and Gene Delivery System Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Drug and Gene Delivery System Introduction
11.2.4 Johnson & Johnson Revenue in Drug and Gene Delivery System Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Drug and Gene Delivery System Introduction
11.3.4 Novartis Revenue in Drug and Gene Delivery System Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Drug and Gene Delivery System Introduction
11.4.4 Roche Revenue in Drug and Gene Delivery System Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Detail
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Drug and Gene Delivery System Introduction
11.5.4 Merck & Co. Revenue in Drug and Gene Delivery System Business (2018-2023)
11.5.5 Merck & Co. Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Drug and Gene Delivery System Introduction
11.6.4 Sanofi Revenue in Drug and Gene Delivery System Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Drug and Gene Delivery System Introduction
11.7.4 GlaxoSmithKline Revenue in Drug and Gene Delivery System Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Drug and Gene Delivery System Introduction
11.8.4 AbbVie Revenue in Drug and Gene Delivery System Business (2018-2023)
11.8.5 AbbVie Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Drug and Gene Delivery System Introduction
11.9.4 AstraZeneca Revenue in Drug and Gene Delivery System Business (2018-2023)
11.9.5 AstraZeneca Recent Development
11.10 Bayer
11.10.1 Bayer Company Detail
11.10.2 Bayer Business Overview
11.10.3 Bayer Drug and Gene Delivery System Introduction
11.10.4 Bayer Revenue in Drug and Gene Delivery System Business (2018-2023)
11.10.5 Bayer Recent Development
11.11 Bristol-MyersSquibb
11.11.1 Bristol-MyersSquibb Company Detail
11.11.2 Bristol-MyersSquibb Business Overview
11.11.3 Bristol-MyersSquibb Drug and Gene Delivery System Introduction
11.11.4 Bristol-MyersSquibb Revenue in Drug and Gene Delivery System Business (2018-2023)
11.11.5 Bristol-MyersSquibb Recent Development
11.12 Celgene
11.12.1 Celgene Company Detail
11.12.2 Celgene Business Overview
11.12.3 Celgene Drug and Gene Delivery System Introduction
11.12.4 Celgene Revenue in Drug and Gene Delivery System Business (2018-2023)
11.12.5 Celgene Recent Development
11.13 Amgen
11.13.1 Amgen Company Detail
11.13.2 Amgen Business Overview
11.13.3 Amgen Drug and Gene Delivery System Introduction
11.13.4 Amgen Revenue in Drug and Gene Delivery System Business (2018-2023)
11.13.5 Amgen Recent Development
11.14 Biogen
11.14.1 Biogen Company Detail
11.14.2 Biogen Business Overview
11.14.3 Biogen Drug and Gene Delivery System Introduction
11.14.4 Biogen Revenue in Drug and Gene Delivery System Business (2018-2023)
11.14.5 Biogen Recent Development
11.15 Gilead Sciences
11.15.1 Gilead Sciences Company Detail
11.15.2 Gilead Sciences Business Overview
11.15.3 Gilead Sciences Drug and Gene Delivery System Introduction
11.15.4 Gilead Sciences Revenue in Drug and Gene Delivery System Business (2018-2023)
11.15.5 Gilead Sciences Recent Development
11.16 Illumina
11.16.1 Illumina Company Detail
11.16.2 Illumina Business Overview
11.16.3 Illumina Drug and Gene Delivery System Introduction
11.16.4 Illumina Revenue in Drug and Gene Delivery System Business (2018-2023)
11.16.5 Illumina Recent Development
11.17 Regeneron Pharmaceuticals
11.17.1 Regeneron Pharmaceuticals Company Detail
11.17.2 Regeneron Pharmaceuticals Business Overview
11.17.3 Regeneron Pharmaceuticals Drug and Gene Delivery System Introduction
11.17.4 Regeneron Pharmaceuticals Revenue in Drug and Gene Delivery System Business (2018-2023)
11.17.5 Regeneron Pharmaceuticals Recent Development
11.18 Vertex Pharmaceuticals
11.18.1 Vertex Pharmaceuticals Company Detail
11.18.2 Vertex Pharmaceuticals Business Overview
11.18.3 Vertex Pharmaceuticals Drug and Gene Delivery System Introduction
11.18.4 Vertex Pharmaceuticals Revenue in Drug and Gene Delivery System Business (2018-2023)
11.18.5 Vertex Pharmaceuticals Recent Development
11.19 Moderna
11.19.1 Moderna Company Detail
11.19.2 Moderna Business Overview
11.19.3 Moderna Drug and Gene Delivery System Introduction
11.19.4 Moderna Revenue in Drug and Gene Delivery System Business (2018-2023)
11.19.5 Moderna Recent Development
11.20 CRISPR Therapeutics
11.20.1 CRISPR Therapeutics Company Detail
11.20.2 CRISPR Therapeutics Business Overview
11.20.3 CRISPR Therapeutics Drug and Gene Delivery System Introduction
11.20.4 CRISPR Therapeutics Revenue in Drug and Gene Delivery System Business (2018-2023)
11.20.5 CRISPR Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock